$COROMANDEL Gains on Subsidy Buzz, But Risks Persist

$COROMANDEL ’s shares have risen 6.5% in three days to ₹1,865.60, on expectations of higher government subsidy support. Yet, the stock remains 20% below pre‑war levels (26 Feb), as the West Asia conflict has sharply raised input costs. With profitability under pressure and visibility limited, investors face a complex mix of near‑term risks and long‑term diversification plans. Financial & Operational Highlights (Q4FY26) EBITDA per tonne: ₹3,500, lowest in eight quarters. Dependence on imports: >80% of ammonia and sulphur sourced overseas, mostly via Strait of Hormuz. Cost pressures: Rupee depreciation, higher freight and insurance costs. Government subsidy: FY26 expenditure ₹2.11 trillion vs estimate ₹1.68 trillion; potential for further hikes. Contribution of subsidy‑linked businesses: 66% of EBITDA in FY26 (vs 71% in FY25). Near‑Term Risks Q1FY27 outlook: Expected to bear brunt of higher input costs. Subsidy uncertainty: Management refrained from EBITDA guidance for FY27. Demand risks: El Niño conditions could affect agricultural activity. Pricing power: Even with subsidies, firms may raise product prices, risking demand. Strategic Diversification Goal: Derive ~50% of profits from non‑subsidy businesses over time. Key driver: Contract development & manufacturing operations (CDMO) for agri and specialty chemicals. Progress: Facilities inspected by multinationals; meaningful CDMO revenue expected only from FY28. Valuation Context Stock trades at 24× FY27 EPS (Bloomberg consensus), not cheap given near‑term uncertainties. Investor sentiment hinges on clarity around subsidy support, cost pass‑through, and execution of diversification strategy.